Description Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist
Estructuralmente, la tirzepatida conserva el dominio N-terminal del GIP necesario para la activacin del receptor GIPR y mantiene afinidad reducida pero funcional por GLP-1R, generando un patrn de sealizacin dual no observado en monoagonistas como semaglutida o liraglutida
In just a few years, GLP-1s have made quite the name for themselves
Furthermore, these agents exert CV benefits by improving endothelial function, reducing inflammation, and lowering blood pressuremechanisms that are particularly relevant in the context of obesity-related CV disease [7]
But they are reshaping the role of fitnessfrom weight loss necessity to a wellness and aesthetic enhancer
They slow stomach emptying and increase fullness, which reduces appetite and calorie intake, leading to gradual weight loss